Literature DB >> 19837271

HMGA2-NFIB fusion in a pediatric intramuscular lipoma: a novel case of NFIB alteration in a large deep-seated adipocytic tumor.

Anne Pierron1, Carla Fernandez, Esma Saada, Frédérique Keslair, Géraldine Hery, Hélène Zattara, Florence Pedeutour.   

Abstract

Lipomas are frequently characterized by aberrations of the 12q13 approximately q15 chromosomal region and often by rearrangements of the HMGA2 gene. These rearrangements include the formation of chimeric genes that fuse the 5' region of HMGA2 with a variety of partners, such as LPP (3q28) or NFIB (9p22). We describe here the fourth reported case of lipoma showing a HMGA2-NFIB fusion, and the first one in a child. We found a translocation t(9;12)(p22;q14) in a deep-seated intramuscular lipoma occurring in the buttock of a 5-year-old boy. By fluorescence in situ hybridization and reverse-transcription polymerase chain reaction, we have shown that the translocation t(9;12) resulted in an in-frame fusion of the first four exons of HMGA2 with the last exon of NFIB. Intramuscular lipomas are very rare in childhood. Our results confirm that lipomas containing NFIB rearrangements may be related to peculiar clinicohistologic features, including large size, deep situation, infiltration of surrounding muscles, or precocious occurrence. Both the truncation of HMGA2 and the nature of its fusion partner gene might be relevant in the adipose tissue tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837271     DOI: 10.1016/j.cancergencyto.2009.06.009

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  NFIB is a potential target for estrogen receptor-negative breast cancers.

Authors:  Hyeong-Gon Moon; Ki-Tae Hwang; Jeong-Ah Kim; Hee Sung Kim; Min-Joo Lee; Eun-Mi Jung; Eunyoung Ko; Wonshik Han; Dong-Young Noh
Journal:  Mol Oncol       Date:  2011-08-08       Impact factor: 6.603

2.  A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.

Authors:  Lisa Mirabello; Roelof Koster; Branden S Moriarity; Logan G Spector; Paul S Meltzer; Joy Gary; Mitchell J Machiela; Nathan Pankratz; Orestis A Panagiotou; David Largaespada; Zhaoming Wang; Julie M Gastier-Foster; Richard Gorlick; Chand Khanna; Silvia Regina Caminada de Toledo; Antonio S Petrilli; Ana Patiño-Garcia; Luis Sierrasesúmaga; Fernando Lecanda; Irene L Andrulis; Jay S Wunder; Nalan Gokgoz; Massimo Serra; Claudia Hattinger; Piero Picci; Katia Scotlandi; Adrienne M Flanagan; Roberto Tirabosco; Maria Fernanda Amary; Dina Halai; Mandy L Ballinger; David M Thomas; Sean Davis; Donald A Barkauskas; Neyssa Marina; Lee Helman; George M Otto; Kelsie L Becklin; Natalie K Wolf; Madison T Weg; Margaret Tucker; Sholom Wacholder; Joseph F Fraumeni; Neil E Caporaso; Joseph F Boland; Belynda D Hicks; Aurelie Vogt; Laurie Burdett; Meredith Yeager; Robert N Hoover; Stephen J Chanock; Sharon A Savage
Journal:  Cancer Discov       Date:  2015-06-17       Impact factor: 39.397

Review 3.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

4.  Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish.

Authors:  Che-Yu Chu; Chi-Fang Chen; R Samuel Rajendran; Chia-Ning Shen; Te-Hao Chen; Chueh-Chuan Yen; Chih-Kuang Chuang; Dar-Shong Lin; Chung-Der Hsiao
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

Review 5.  Intramuscular lipoma: a review of the literature.

Authors:  Shane McTighe; Ivan Chernev
Journal:  Orthop Rev (Pavia)       Date:  2014-12-16

6.  Fusion of the HMGA2 and C9orf92 genes in myolipoma with t(9;12)(p22;q14).

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Antonio Agostini; Ingvild Lobmaier; Bodil Bjerkehagen; Sverre Heim
Journal:  Diagn Pathol       Date:  2016-02-09       Impact factor: 2.644

Review 7.  Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.

Authors:  Daiana D Becker-Santos; Kim M Lonergan; Richard M Gronostajski; Wan L Lam
Journal:  EBioMedicine       Date:  2017-05-27       Impact factor: 8.143

Review 8.  High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.

Authors:  Uchenna Unachukwu; Kiran Chada; Jeanine D'Armiento
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

9.  HMGA2: A Biomarker in Gynecologic Neoplasia.

Authors:  Jian-Jun Wei
Journal:  J Clin Transl Pathol       Date:  2022-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.